the Significance of CA15-3 in Breast Cancer Screening - Breast and Thyroid

Share to:

The CA15-3 marker is a tumor marker used in the blood test for breast cancer. It is primarily utilized to monitor treatment response and disease progression in patients already diagnosed with breast cancer, rather than for initial screening or diagnosis. Elevated levels of CA15-3 may indicate the presence of breast cancer or its recurrence, but it is not specific to breast cancer alone and can be elevated


Hello Dr.
Zhao, I would like to ask about the significance of the breast cancer blood marker CA15-3.
If this marker is normal, does that mean there is no need for breast ultrasound or mammography? Since this marker is included in my annual health check-ups, I would like to understand its significance and how it differs from breast ultrasound.
Additionally, I had a unilateral fibroid removed at the age of 20, and at that time, both breasts had fibroids, but the doctor recommended removing one side for biopsy, which resulted in a benign fibroid.
Until two years ago, my health check-up report still indicated "low echo irregular nodules," while the CA15-3 marker was normal.
When I asked the doctor about the nodules, he said there was no need to worry.
I would also like to ask you, Dr.
Zhao, what does "nodules" mean? Should I continue to have regular ultrasound follow-ups, or is it sufficient to monitor as long as the CA15-3 marker is normal? Thank you for taking the time to answer!

Sharon, 30~39 year old female. Ask Date: 2006/11/06

Dr. Zhao Ming reply Breast and Thyroid


CA 15-3 is recommended for breast cancer screening, as the majority of newly diagnosed breast cancer cases have normal CA 15-3 levels.
Early detection of breast cancer relies on regular breast examinations (clinical breast exams), mammography, and ultrasound, which provide the opportunity for early identification of breast cancer.
Dr.
Zhao Ming.

Reply Date: 2006/11/06

More Info


CA15-3 is a tumor marker that is primarily used in the monitoring of breast cancer, particularly in patients who have already been diagnosed with the disease. It is important to understand that while CA15-3 can provide valuable information regarding the presence of breast cancer, it is not a definitive screening tool for early detection. The significance of CA15-3 lies in its ability to indicate the presence of cancer cells in the body, but it is not used as a standalone diagnostic tool.
In clinical practice, CA15-3 levels can be elevated in various conditions, not just breast cancer. For instance, benign breast diseases, liver diseases, and even during pregnancy can lead to increased levels of CA15-3. Therefore, a normal CA15-3 level does not necessarily mean that breast cancer is absent, nor does it eliminate the need for regular breast examinations, including mammograms and ultrasounds.
Mammography and breast ultrasound are essential tools for the early detection of breast cancer. Mammograms can identify abnormalities in breast tissue that may not be palpable during a physical examination, while ultrasounds can provide additional information about the characteristics of breast masses. These imaging modalities are crucial for detecting breast cancer at an early stage when it is most treatable.
Regarding your previous history of a benign fibroadenoma and the current findings of "low echo irregular nodules," it is essential to continue monitoring these changes through regular imaging. The term "nodule" refers to a small, rounded mass of tissue, which can be benign or malignant. The irregularity of the nodules may warrant further investigation, especially if there are changes over time.
Given your medical history and the presence of nodules, it is advisable to maintain regular follow-ups with your healthcare provider, including breast ultrasounds and mammograms, regardless of the CA15-3 levels. Regular monitoring can help ensure that any changes in your breast tissue are detected early, allowing for timely intervention if necessary.

In summary, while CA15-3 is a useful marker in the context of breast cancer management, it should not replace routine breast imaging and clinical examinations. Regular screenings are vital for early detection and management of breast cancer, especially for individuals with a history of breast abnormalities. It is always best to discuss your specific situation with your healthcare provider, who can tailor a monitoring plan based on your unique medical history and risk factors.

Similar Q&A

Understanding CEA and CA15-3 Levels After Breast Cancer Treatment

Hello Doctor: My mother has stage III breast cancer and has completed four rounds of chemotherapy before surgery and six rounds after surgery. She has also just finished radiation therapy. I would like to ask about her lab results. Before the surgery, after the first four rounds ...


Dr. Chen Sirong reply Oncology
Dear Xiao Guang, The normal range for CEA is 0-10.0, and for CA-153, it is approximately 0-31, though values may vary slightly between different hospitals. In this case, it cannot be concluded whether there are residual cancer cells based solely on these values. Generally, if th...

[Read More] Understanding CEA and CA15-3 Levels After Breast Cancer Treatment


Understanding CA-153 Levels: What to Do When It's 50.1 in an 86-Year-Old

My mother recently had a health check-up and her CA 15-3 level was found to be 50.1. Given her advanced age of 86, how should we proceed with this situation? She currently has a history of hypertension and gastroesophageal reflux disease.


Dr. Chen Sirong reply Oncology
Ms. Chuo / 55 / CA 15-3 is commonly used clinically for breast cancer, third trimester of pregnancy, some patients with cirrhosis, more active lung cancer, ovarian cancer, cervical cancer, and endometrial cancer, among others. It may sometimes also cause a slight increase in CA 1...

[Read More] Understanding CA-153 Levels: What to Do When It's 50.1 in an 86-Year-Old


Understanding Elevated CA15-3 Levels and Ovarian Health Concerns

Hello doctor, I previously had a check-up at the obstetrics and gynecology department, and I have some issues with my ovaries. Recently, I had my annual health examination, and my CA 15-3 level was 33, which is slightly higher than the normal range. Could my ovarian issues be aff...


Dr. Chen Zhiyu reply Obstetrics and Gynecology
Regarding your concerns, tumor markers can help indicate potential tumor conditions in the body, but sometimes they may not provide a definitive diagnosis. This aspect may require further evaluation through medical consultation and actual examination results for more accurate ass...

[Read More] Understanding Elevated CA15-3 Levels and Ovarian Health Concerns


Understanding T15 Tumor Marker Test Results: Next Steps for Patients

Hello Doctor, I recently underwent a T15 tumor marker test, and the results showed two markers exceeding the normal range. The first one is carbohydrate antigen CA72-4 with a result of 23.6, where the reference value is <5.3 U/ml. The second one is tumor marker CA125 with a re...


Dr. Lin Zongzhe reply Oncology
Hello! The interpretation of serum tumor markers often requires correlation with medical history and other clinical examinations to be meaningful. Many benign non-tumor diseases or even normal individuals may occasionally exhibit slight elevations in tumor markers. You may inquir...

[Read More] Understanding T15 Tumor Marker Test Results: Next Steps for Patients


Related FAQ

Breast Cancer

(Breast and Thyroid)

Breast Examination

(Breast and Thyroid)

Breast Calcification

(Breast and Thyroid)

Goiter

(Breast and Thyroid)

Fibroadenoma

(Breast and Thyroid)

Areola

(Breast and Thyroid)

Axilla

(Breast and Thyroid)

Hyperthyroidism

(Breast and Thyroid)

Axillary Lump

(Breast and Thyroid)

Armpit

(Breast and Thyroid)